It may be interesting to investigate the role of endogenous CRF in high fat diet-induced hepatic steatosis and inflammation using a potent CRF antibody or antagonist in an experimental NAFLD model. The gene discussed is CRH; the disease is metabolic dysfunction-associated steatotic liver disease.